DENVER--(BUSINESS WIRE)--Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, today announced the launch of Cleerly ISCHEMIA, which recently received U.S.

A new study connects dairy to some benefits for your heart—here's what to know.

This unexpected ability opens the door for scientists to stimulate cellular mitosis and improve heart function after an ...

AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

Allopurinol, a drug commonly used to treat gout, provided no benefit in terms of reducing cardiovascular (CV) events in patients with ischemic heart disease, new randomized trial results show.

Understanding the mechanisms behind cell death and survival is crucial when it comes to conditions like heart failure, which affects millions of people worldwide. Now, researchers from Japan have ...

February is filled with reminders of love and health. Beyond Valentine’s Day, February is an “awareness month” for both ...

We're excited to support a new $55m global research programme called VISIBLE from Wellcome Leap - jointly funded by Pivotal - ...